Drug Shortage Report for JAMP-DOXAZOSIN
Report ID | 160747 |
Drug Identification Number | 02489937 |
Brand name | JAMP-DOXAZOSIN |
Common or Proper name | Doxazosin Tablets, USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DOXAZOSIN |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 (bottle) |
ATC code | C02CA |
ATC description | ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-12 |
Estimated end date | 2022-07-25 |
Actual end date | 2022-07-25 |
Shortage status | Resolved |
Updated date | 2022-07-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-07-27 | French | Compare |
v5 | 2022-07-27 | English | Compare |
v4 | 2022-07-19 | French | Compare |
v3 | 2022-07-19 | English | Compare |
v2 | 2022-05-17 | French | Compare |
v1 | 2022-05-17 | English | Compare |
Showing 1 to 6 of 6